Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
AtriCure, Inc. - Common Stock
(NQ:
ATRC
)
39.07
-0.95 (-2.37%)
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 23, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about AtriCure, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
AtriCure Reports Second Quarter 2022 Financial Results
August 02, 2022
From
AtriCure, Inc.
Via
Business Wire
AtriCure to Participate at Upcoming Investor Conferences
July 20, 2022
From
AtriCure, Inc.
Via
Business Wire
5 Analysts Have This to Say About AtriCure
↗
July 18, 2022
Over the past 3 months, 5 analysts have published their opinion on AtriCure (NASDAQ:ATRC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
AtriCure to Announce Second Quarter 2022 Financial Results
July 12, 2022
From
AtriCure, Inc.
Via
Business Wire
Analyst Ratings for AtriCure
↗
June 28, 2022
Over the past 3 months, 4 analysts have published their opinion on AtriCure (NASDAQ:ATRC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
AtriCure Announces the First Patient Treated in the HEAL-IST Clinical Trial
June 07, 2022
From
AtriCure, Inc.
Via
Business Wire
AtriCure Announces the Appointment of Deborah Yount as Chief Human Resources Officer
June 01, 2022
From
AtriCure, Inc.
Via
Business Wire
AtriCure's Q1 EPS Miss Estimates, Needham Lowers Price Target
↗
May 04, 2022
Needham lowered AtriCure Inc's (NASDAQ: ATRC) price target to $67 from $79 due to peer multiple compression, with the Buy rating unchanged.
Via
Benzinga
4 Analysts Have This to Say About AtriCure
↗
May 04, 2022
Over the past 3 months, 4 analysts have published their opinion on AtriCure (NASDAQ:ATRC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
AtriCure: Q1 Earnings Insights
↗
May 03, 2022
AtriCure (NASDAQ:ATRC) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings AtriCure missed estimated earnings by...
Via
Benzinga
AtriCure Reports First Quarter 2022 Financial Results
May 03, 2022
From
AtriCure, Inc.
Via
Business Wire
AtriCure Launches EnCompass® Clamp, a part of Isolator Synergy™ Ablation System
April 12, 2022
From
AtriCure, Inc.
Via
Business Wire
AtriCure to Announce First Quarter 2022 Financial Results
April 11, 2022
From
AtriCure, Inc.
Via
Business Wire
AtriCure Reports Deeper Losses In Q4 Despite 27% Jump In Sales, Issues FY22 Guidance
↗
February 16, 2022
AtriCure Inc (NASDAQ: ATRC) reported Q4
Via
Benzinga
Recap: AtriCure Q4 Earnings
↗
February 15, 2022
AtriCure (NASDAQ:ATRC) reported its Q4 earnings results on Tuesday, February 15, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings AtriCure missed estimated earnings...
Via
Benzinga
AtriCure Reports Fourth Quarter 2021 and Full Year 2021 Financial Results
February 15, 2022
From
AtriCure, Inc.
Via
Business Wire
The Daily Biotech Pulse: Larimar Plunges On Extension Of Clinical Hold, ImmunityBio Gains On Positive Data, Adcom Test Awaits Avenue Therapeutics
↗
February 15, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus ImmunityBio Says Cancer Combo Therapy Produces Positive Results In Late-Stage...
Via
Benzinga
Earnings Scheduled For February 15, 2022
↗
February 15, 2022
Companies Reporting Before The Bell • FirstService (NASDAQ:FSV) is estimated to report quarterly earnings at $1.31 per share on revenue of $1.07 billion.
Via
Benzinga
A Preview Of AtriCure's Earnings
↗
February 14, 2022
AtriCure (NASDAQ:ATRC) is set to give its latest quarterly earnings report on Tuesday, 2022-02-15. Here's what investors need to know before the announcement. Analysts estimate that AtriCure will...
Via
Benzinga
The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More
↗
February 13, 2022
Biotech stocks moved back and forth amid some volatility before finishing the week ending Feb. 11 modestly lower, reversing the gains from the previous week. Earnings news...
Via
Benzinga
AtriCure Publishes Inaugural ESG Report
February 08, 2022
From
AtriCure, Inc.
Via
Business Wire
AtriCure to Participate in the 11th Annual SVB Leerink Global Healthcare Conference
February 01, 2022
From
AtriCure, Inc.
Via
Business Wire
AtriCure to Announce Fourth Quarter and Full Year 2021 Financial Results
January 25, 2022
From
AtriCure, Inc.
Via
Business Wire
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2021, Provides Financial Outlook for 2022
January 10, 2022
From
AtriCure, Inc.
Via
Business Wire
AtriCure to Participate in the 40th Annual J.P. Morgan Healthcare Conference
December 20, 2021
From
AtriCure, Inc.
Via
Business Wire
AtriCure to Participate in Upcoming Piper Sandler 33rd Annual Virtual Healthcare Conference
November 12, 2021
From
AtriCure, Inc.
Via
Business Wire
AtriCure, inc (ATRC) Q3 2021 Earnings Call Transcript
↗
November 04, 2021
ATRC earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
AtriCure Reports Third Quarter 2021 Financial Results
November 03, 2021
From
AtriCure, Inc.
Via
Business Wire
The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering
↗
November 03, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Horizon Announces Retirement Of CFO, Beat-and-raise Q3 Horizon Therapeutics...
Via
Benzinga
Topics
Retirement
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
↗
October 31, 2021
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
